This suggested that targeting ZNRF2 may inhibit immunosuppressive cells in THCA, thereby reversing the immunosuppressive microenvironment and enhancing the ability of anticancer immune cells to kill tumour cells. This evidence concerns the gene ZNRF2 and neoplasm.